Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy.

Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Abstract Text:

    nicola brunetti-pierriNicola Brunetti-Pierri,philip ngPhilip Ng,

    This review focuses on recent developments in helper-dependent adenoviral technology and preclinical studies for helper-dependent adenovirus-mediated liver- and lung-directed gene therapy. Studies highlighting the tremendous potential of these vectors are reviewed, together with some important obstacles that will need to be addressed before clinical utility.

    Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Publishing Authors By Initials

    n brunetti-pierriN Brunetti-Pierri,p ngP Ng,

    For similar respiratory tract diseases: lung diseases research abstracts see: respiratory tract diseases: lung diseases research

    PUBMED ID PMID:

    MEDLINE DATE:

    Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Current opinion in molecular therapeutics

    VOLUME: 8

    Page Numbers: 446-54

    Journal Abbreviation: Curr. Opin. Mol. Ther.

    ISSN: 1464-8431

    DAY: 3

    MONTH: Oct

    YEAR: 2006

    Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100891485

    Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Keywords Mesh Terms:

    KEYWORDS: Lung Diseases

    MESH TERMS: therapy

    Chemical & Substance for Abstract: Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy.

    AFFILIATION: Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza T619, Houston, TX 77030, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NHLBI

    GRANT: P50 HL59314

    ACRONYM: HL

    MEDLINETA: Curr Opin Mol Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News